| [1] |
陈世发, 赵礼金. 肝癌发生发展机制的研究进展及其治疗现状. 中国普通外科杂志, 2018, 27:910-923.
|
| [2] |
Imawari Y, Mimoto R, Hirooka S, et al.Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer. Cancer Sci, 2018, 109:363-372.
|
| [3] |
Singh R, Lauth M.Emerging roles of DYRK kinases in embryogenesis and hedgehog pathway control. J Dev Biol, 2017, 5:13-16.
|
| [4] |
Ito D, Yogosawa S, Mimoto R, et al.Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer. Cancer Sci, 2017, 108:1565-1573.
|
| [5] |
Taira N, Nihira K, Yamaguchi T, et al.DYRK2 is targeted to the nucleus and controls p53 via ser46 phosphorylation in the apoptotic response to DNA damage. Mol Cell, 2007, 25:725-738.
|
| [6] |
Taira N, Mimoto R, Kurata M, et al.DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells. J Clin Invest, 2012, 122:859-872.
|
| [7] |
Mimoto R, Taira N, Takahashi H, et al.DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail. Cancer Lett, 2013, 339:214-225.
|
